ASX - Delayed Quote AUD
Memphasys Limited (MEM.AX)
At close: 4:10 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
60.0000
60.0000
15.3710
27.1480
--
Cost of Revenue
58.3940
58.3940
6.1500
18.9050
--
Gross Profit
1.6060
1.6060
9.2210
8.2430
--
Operating Expense
5,240.3360
5,240.3360
3,643.0390
2,741.5040
1,960.9990
Operating Income
-5,238.7300
-5,238.7300
-3,633.8180
-2,733.2610
-1,960.9990
Net Non Operating Interest Income Expense
-417.1330
-417.1330
-414.9440
-568.9680
-86.9710
Other Income Expense
1,213.8420
1,213.8420
646.1440
1,220.2650
302.0520
Pretax Income
-4,442.0210
-4,442.0210
-3,402.6180
-2,081.9640
-1,486.4320
Net Income Common Stockholders
-4,442.0210
-4,442.0210
-3,402.6180
-2,081.9640
-1,486.4320
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Basic Average Shares
2,310,465.3300
2,310,465.3300
1,922,337.1400
858,134.4460
827,876.1720
Diluted Average Shares
2,310,465.3300
2,310,465.3300
1,922,337.1400
858,134.4460
827,876.1720
Net Income from Continuing & Discontinued Operation
-4,442.0210
-4,442.0210
-3,402.6180
-2,081.9640
-1,486.4320
Normalized Income
-4,442.0210
-4,442.0210
-3,402.6180
-2,081.9640
-1,486.4320
Interest Income
0.7090
--
13.2530
0.7090
2.5430
Interest Expense
318.7090
318.7090
316.7770
452.6590
25.3390
Net Interest Income
-417.1330
-417.1330
-414.9440
-568.9680
-86.9710
EBIT
-4,123.3120
-4,123.3120
-3,085.8410
-1,629.3050
-1,461.0930
EBITDA
-3,406.1490
-3,406.1490
-2,473.0020
-1,506.0940
-1,201.6070
Reconciled Cost of Revenue
58.3940
58.3940
6.1500
18.9050
--
Reconciled Depreciation
717.1630
717.1630
612.8390
123.2110
259.4860
Net Income from Continuing Operation Net Minority Interest
-4,442.0210
-4,442.0210
-3,402.6180
-2,081.9640
-1,486.4320
Normalized EBITDA
-3,406.1490
-3,406.1490
-2,473.0020
-1,506.0940
-1,201.6070
6/30/2021 - 5/11/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYP.AX Cynata Therapeutics Limited
0.2250
-2.17%
MDC.AX Medlab Clinical Limited
6.60
0.00%
BIT.AX Biotron Limited
0.0190
0.00%
AVE.AX Avecho Biotechnology Limited
0.0020
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0600
+1.69%
CMB.AX Cambium Bio Limited
0.4100
0.00%
CHM.AX Chimeric Therapeutics Limited
0.0120
+20.00%
BTC.AX BTC Health Limited
0.0480
-4.00%
IXC.AX Invex Therapeutics Ltd
0.0900
0.00%
IMC.AX Immuron Limited
0.0750
-3.85%